Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 128-133, 2013.
Artigo em Chinês | WPRIM | ID: wpr-749569

RESUMO

OBJECTIVE@#To evaluate the long-term efficacy of submandibular gland transfer for prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma.@*METHOD@#Sixty-five cases of nasopharyngeal carcinoma patients were randomly divided into study group of 32 patients and control group of 33 patents. The submandibular gland was transferred to submental region on 32 cases with nasopharyngeal carcinoma before receiving conventional radiotherapy and a block was used to cover the submental region. Before radiotherapy, two groups of submandibular gland function was detected by imaging of the submandibular gland. At 60 months after radiotherapy, submandibular gland function was detected by 99mTc radionuclide scanning, the questionnaire about the degree of xerostomia was investigated respectively. Five-year survival rate was counted.@*RESULT@#After following up for 60 months, submandibular gland uptake and secretion function in the study group was significantly higher than that in the control group, there was significant difference between the two groups (P 0.05).@*CONCLUSION@#The long-term efficacy of submandibular gland transfer for prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma was well. It could improve the quality of life in nasopharyngeal carcinoma patients after radiotherapy, and did not affect the long-term efficacy of nasopharyngeal carcinoma.


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Carcinoma , Carcinoma Nasofaríngeo , Neoplasias Nasofaríngeas , Radioterapia , Cirurgia Geral , Estudos Prospectivos , Radioterapia , Glândula Submandibular , Cirurgia Geral , Xerostomia
2.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 410-412, 2013.
Artigo em Chinês | WPRIM | ID: wpr-749513

RESUMO

OBJECTIVE@#To raise clinical awareness of carcinoembryonic antigen(CEA) increased as initial manifestation of medullary thyroid cancer(MTC) and explore the diagnosis and treatment.@*METHOD@#Clinical data of 2 cases CEA increased as the initial presentation of MTC were retrospectively analyzed and clinical manifestations of the disease, diagnosis, treatment were also discussed by literature reviewing.@*RESULT@#Two patients received thyroid ipsilateral lobe total resection, MTC was confirmed by intraoperative frozen pathology, re-total resection of the contralateral lobe and bilateral VI lymph node dissection were performed. Lymph nodes had no metastasis confirmed by pathological frozen examination. CEA returned to normal within 2 months after surgery. No tumor recurrence and metastasis were found after follow-up for 3 to 24 months.@*CONCLUSION@#CEA increased as the initial presentation MTC was rare and clinical identification of CEA increased disease should be taken into account the MTC as possible. Total thyroidectomy and bilateral VI lymph node dissection was the main surgical treatment for it.


Assuntos
Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Antígeno Carcinoembrionário , Metabolismo , Carcinoma Neuroendócrino , Estudos Retrospectivos , Neoplasias da Glândula Tireoide , Metabolismo , Patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA